Editorial: The R-E-S-P-E-C-T IssueWhere respect has faltered—and how physicians can reclaim it. VTE risk with newer hormonal contraceptivesVenous thromboembolism is a recognized adverse event linked to hormonal contraceptives, with an increased risk related to higher estrogen dose and progestin type, in particular depot medroxyprogesterone acetate. Are you the starting point? Pharmacists often tell us that while they appreciate the information we provide, they just don’t have the time to practice to their full capability. When generations collide Differing values, misunderstandings and assumptions can be a prescription for disrespect. Have you ever felt disrespected? Physicians recall some less-than-courteous moments in their career. December drug news roundup: Five new products pharmacists and physicians should know about Get the info you need on these new products, part of our drug news roundup for December. Drug News—December 2025 A review of new launches, new indications, new dosage forms and Health Canada advisories. NEW PRODUCT: Rystiggo for myasthenia gravis Get the info you need on this new product, part of our drug news roundup for December. NEW PRODUCT: Tzield to delay onset of stage 3 type 1 diabetes Get the info you need on this new product, part of our drug news roundup for December. Where integrative care fuels connection Inside Opal Wellness Pharmacy, patients find personalized services and honest conversations. 1 2 3 4 5 Next Last
